Ocrelizumab

Ocrelizumab is a humanized monoclonal antibody directed against CD20 present on B‑lymphocytes. Ocrelizumab is used to treat of relapsing forms of multiple sclerosis.

What can Sanquin do for you?

Measure drug levels of free drug in the serum using an validated ELISA.
Measure the immunogenicity of ocrelizumab.
Provide assay reagents or co-develop novel testing strategies.
Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected].

Last edited on: 23 November 2022